Rocket Lab (NASDAQ: RKLB) closed a recent Friday session at $63.91, down 8.7% in a single day and roughly 58% below its 52-week high of $151.
The average price target across the 17 analysts covering RKLB stock sits at $114.33, approximately 79% above the current share price.
A gap that wide between the market price and analyst targets means at least one side is making a significant miscalculation about the company’s value.
The central point of disagreement is the planned $8 billion acquisition of satellite operator Iridium Communications (NASDAQ: IRDM), announced on June 29.
Under the deal terms, Iridium stockholders would receive $54 per share, consisting of $27 in cash plus Rocket Lab stock through an exchange ratio with a specific collar.
That collar assumes Rocket Lab shares trade between $67.50 and $112.50, meaning the current price sits below the deal structure’s floor.
Rocket Lab CEO Peter Beck described the agreement as “a defining moment for the space industry,” pointing to Iridium’s established global satellite network as the strategic prize.
Iridium generated $871.7 million of revenue in 2025, with operational earnings before interest, taxes, depreciation, and amortization of $495 million, representing a 57% margin.
To fund the cash portion of the deal, Rocket Lab secured a $3.6 billion bridge loan, with additional debt and equity issuances expected to cover the remainder.
That is a substantial financing burden for a company that generated roughly $680 million of revenue over the past 12 months and has not yet reached profitability.
The deal is not expected to close until mid-2027, meaning financing uncertainty could weigh on the stock for an extended period.
Despite the deal-related pressure, the underlying business continues to deliver strong operational results that most bears would be hard-pressed to dismiss entirely.
First-quarter revenue rose approximately 63% year over year to a record $200.3 million, while the GAAP net loss narrowed to $45 million during the same period.
The company’s backlog climbed to a record $2.2 billion, representing roughly 20% growth in a single quarter, signaling healthy demand for its launch and space systems services.
Management guided for another record in the second quarter, forecasting revenue between $225 million and $240 million as the business continues to scale rapidly.
On July 21, the U.S. Space Force awarded Rocket Lab a $266 million contract for 12 suborbital launch missions from Alaska’s Kodiak spaceport, the largest government launch award in the company’s history.
The contract also includes options for six additional missions through 2028, worth approximately 39% of Rocket Lab’s trailing-12-month revenue in total potential value.
Analyst reactions to the Iridium deal were mixed but largely optimistic, with Bank of America lifting its target to $115, while Roth Capital and Citizens both moved to $130.
New Street Research initiated coverage at a street-high target of $150, representing a bullish bet that the complex financing structure ultimately lands without significant dilution or disruption.
Piper Sandler offered the most cautious recent perspective, initiating coverage with a Neutral rating and an $83 price target, sitting about 27% below the current analyst consensus figure.
When the newest analyst view in a 17-person group lands that far below the average, the consensus starts to look less like agreement and more like a debate centered on an $8 billion leveraged acquisition.
Rocket Lab currently carries a market value of roughly $38 billion, or approximately 56 times its trailing-12-month revenue, a valuation that demands years of execution across both Neutron launches and satellite growth.
The debut launch of the larger Neutron rocket remains on track for later this year, which could serve as a meaningful catalyst if it proceeds on schedule.
The broader space sector has also cooled considerably, with SpaceX having roughly halved from the peak it reached shortly after its June initial public offering, adding sector-wide headwinds to RKLB’s stock pressure.
